![David Patience](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/07/2026
David Patience is Chief Financial Officer at TriSalus Life Sciences, Inc. since 2025.
Previously, Chief Financial Officer at Accelerate Diagnostics, Inc. from 2023 to 2025.
Education includes an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Leeds School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/07/2026 | 261.107 ( 0,43 % ) | 1 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Director Financiero/CFO | 01/07/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| ACCELERATE DIAGNOSTICS, INC. | Director Financiero/CFO | 30/06/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Accelerate Diagnostics, Inc.
 Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leeds School of Business
 The Leeds School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TriSalus Life Sciences, Inc.
 TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
